Rate Shows / BiotechTV - News Your browser cannot play this audio here. This plays from the publisher's own server. We do not host a copy.
Open at the source
Not rated yet Not interested: Jefferies London 2026: Protagonist Therapeutics' CEO Dinesh Patel discusses the launch of ICOTYDE, and the company's pipeline, which is well funded now due to commercial success Clear rating for Jefferies London 2026: Protagonist Therapeutics' CEO Dinesh Patel discusses the launch of ICOTYDE, and the company's pipeline, which is well funded now due to commercial success
Save for later In Library Jefferies London 2026: Protagonist Therapeutics' CEO Dinesh Patel discusses the launch of ICOTYDE, and the company's pipeline, which is well funded now due to commercial success Description He comments on the early days of JNJ's ICOTYDE launch, developing an optimized IL-17, the obesity space, and more.
Back to BiotechTV - News · Report a problem